Dr. Rachel Karpel served for 12 years at the Israel Ministry of Health. In her last position, as the Director of the Institute for Standardization and Control of Pharmaceuticals at the Israeli Ministry of Health she was involved in policy making and oversight of the GMP Inspectorate, determining national policies regarding GMP and quality of pharmaceuticals as well as initiating the establishment of the Department for Quality Assessment of Biological Products at the Ministry of Health.  Dr Karpel was also responsible for coordination with PIC/S and for negotiations with the European Commission regarding a mutual recognition agreement for GMP inspections.
Dr. Karpel is an active member of the Israel Chapter of PDA.  She lectures at Ben Gurion University providing pharmacy students with an introduction to the regulation and control of pharmaceuticals.
Dr. Karpel joined PCI Pharmaceutical Consulting Ltd. in 2006 as a Senior Associate, providing consultancy services to the pharmaceutical and allied industries in Israel and worldwide